Update on endovascular treatment of cerebrovascular diseases

Journal of Endovascular Therapy

Volumn 11, Issue SUPPL. 2, 2004, Pages

  Hussain, M Shazam ^a   Qureshi, Adnan I ^a,c   Kirmani, Jawad F ^a   Divani, Afshin A ^a   Hopkins, L Nelson ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Doctor's Office Center   (United States)

Author keywords

Aneurysm; Arteriovenous malformation; Coil embolization; Intracranial arteries; Liquid embolic agents; Percutaneous transluminal angioplasty; Stenosis; Stent; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; ENBUCRILATE; ETHYLENE VINYL ALCOHOL COPOLYMER; FIBRINOLYTIC AGENT; RETEPLASE; SARUPLASE; UROKINASE;

ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COIL EMBOLIZATION; CORONARY STENT; ENDOVASCULAR SURGERY; HUMAN; INTRACRANIAL ANEURYSM; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; STENOSIS; TECHNIQUE; TREATMENT INDICATION;

EID: 12144256667     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/04-1383.1     Document Type: Review

References (77)

1. Kalache A, Aboderin I. Stroke: the global burden. Health Policy Plan. 1995;10:1-21.
2. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol. 1997;29:1269-1275.
3. Fessler RD, Wakhloo AK, Lanzino G, et al. Transradial approach for vertebral artery stenting: technical case report. Neurosurgery. 2000;46:1524-1528.
4. Seldinger SI. Catheter replacement of the needle in percutaneous angiography: a new technique. Acta Radiol. 1953;39:368-376.
5. Moran CJ, Cross D, Talcott M, et al. Magnetically controlled endovascular navigation: in vivo experience [Abstract]. J Neurosurg. 2000;92:205.
6. Sussman BJ, Fitch TS. Thrombolysis with fibrinolysis in cerebral arterial occlusion. JAMA. 1958;167:1705-1709.
7. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
8. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
9. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283:1145-1150.
10. Qureshi AI, Ringer AJ, Suri MF, et al. Acute interventions for ischemic stroke: present status and future directions. J Endovasc Ther. 2000;7:423-428.
11. Qureshi AI, Ali Z, Suri MF, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery. 2001;49:41-50.
12. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery. 2002;51:1319-1329.
13. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra early thrombolytic therapy. AJNR Am J Neuroradiol. 1996;17:79-85.
14. Furlan A, Higashida R, Wechsler L, et al. Intraarterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003-2011.
15. Chalela JA, Katzan I, Liebeskind DS, et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke. 2001;32:1365-1369.
16. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
17. Sen S, Agarwal P, Eskhar N, et al. Differential response to intravenous versus intra-arterial thrombolysis in acute ischemic stroke on the basis of hyperdense middle cerebral artery sign [Abstract]. Stroke. 2003;34:285.
18. Qureshi AI. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery. 2002;50:1405-1415.
19. Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2094-2100.
20. Ueda T, Sakaki S, Kumon Y, et al. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2360-2365.
21. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4-11.
22. Qureshi AI, Suri MF, Shatla AA, et al. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen. Neurosurgery. 2000;47:473-479.
23. Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator(r-TPA). Neuroradiology. 1993;35:159-162.
24. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
25. The IMS Investigators. The Interventional Management of Stroke (IMS) Study: safety results [Abstract]. Stroke. 2003;34:247.
26. Kim S, Siddiqui A, Hanel R, et al. Mechanical thrombolysis for acute ischemic stroke. Neurointerventionist. 2003;4:15-22.
27. Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol. 2003;24:534-538.
28. Berlis A, Lutsep H, Barnwell S, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke. 2004;35:1112-1116.
29. Starkman S, Gobin YP, Duckwiler GR, et al. Mechanical embolus removal in cerebral ischemia (MERCI) trial. 7th International Symposium on Thrombolysis and Acute Stroke Therapy, Lyons, France, May 2002.
30. Eckert B, Koch C, Thomalla G, et al. Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: report of 3 cases. Stroke. 2002;33:1424-1427.
31. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996;27:1974-1980.
32. Qureshi Al, Ziai WC, Yahia AM, et al. Stroke free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery. 2003;52:1033-1040.
33. Bogousslavsky J, Barnett HJ, Fox AJ, et al. Atherosclerotic disease of the middle cerebral artery. Stroke. 1986;17:1112-1120.
34. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology, 1995;45:1488-1493.
35. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology. 2000;55:490-497.
36. Ali Z, Qureshi AI, Suri MF, et al. Single-center study to evaluate long-term effectiveness of angioplasty and/or stent placement for intracranial atherosclerotic disease [Abstract]. Neurology. 2002;58:A313.
37. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30:1065-1069.
38. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke. 2000;31:95-99.
39. Lutsep HL, Barnwell SL, Mawad M, et al. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results [Abstract]. Stroke. 2003;34:253.
40. Rinkel GJ, Djibuti M, Algra A, et al. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29:251-256.
41. Guglielmi G, Vinuela F, Sepetka I, et al. Electrothrombosis of saccular aneurysms via endovascular approach. Electrochemical basis, technique, and experimental results. J Neurosurg. 1991;75:1-7.
42. Macdonald RL, Mojtahedi S, Johns L, et al. Randomized comparison of Guglielmi detachable coils and cellulose acetate polymer for treatment of aneurysms in dogs. Stroke. 1998;29:478-486.
43. Stiver SI, Porter PJ, Willinsky RA, et al. Acute human histopathology of an intracranial aneurysm treated using Guglielmi detachable coils: case report and review of the literature. Neurosurgery. 1998;43:1203-1208.
44. Qureshi AI, Suri MF, Khan J, et al. Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility. J Neurosurg. 2001;94:880-885.
45. Cottier JP, Pasco A, Gallas S, et al. Utility of balloon-assisted Guglielmi detachable coiling in the treatment of 49 cerebral aneurysms: a retrospective, multicenter study. AJNR Am J Neuroradiol. 2001;22:345-351.
46. Lanzino G, Wakhloo AK, Fessier RD, et al. Efficacy and current limitations of intravascular stents for intracranial internal carotid, vertebral, and basilar artery aneurysms. J Neurosurg. 1999;91:538-546.
47. Raymond J, Guilbert F, Roy D. Neck-bridge device for endovascular treatment of wide-neck bifurcation aneurysms: initial experience. Radiology. 2001;221:318-326.
48. Mawad ME, Cekirge S, Ciceri E, et al. Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection. J Neurosurg. 2002;96:474-482.
49. Sedat J, Dib M, Lonjon M, et al. Endovascular treatment of ruptured intracranial aneurysms in patients aged 65 years and older: follow-up of 52 patients after 1 year. Stroke. 2002;33:2620-2625.
50. Kremer C, Groden C, Hansen HC, et al. Outcome after endovascular treatment of Hunt and Hess grade IV or V aneurysms: comparison of anterior versus posterior circulation. Stroke. 1999;30:2617-2622.
51. Vallee JN, Aymard A, Vicaut E, et al. Endovascular treatment of basilar tip aneurysms with Guglielmi detachable coils: predictors of immediate and long-term results with multivariate analysis 6-year experience. Radiology. 2003;226:867-879.
52. Johnston SC, Higashida RT, Barrow DL, et al. Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke. 2002;33:2536-2544.
53. Baltsavias GS, Byrne JV, Halsey J, et al. Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes. Neurosurgery. 2000;47:1320-1331.
54. Morizane A, Nakahara I, Sakai N, et al. Endovascular surgery for untreated ruptured aneurysm with symptomatic vasospasm [in Japanese]. No Shinkei Geka. 1999;27:941-946.
55. Brilstra EH, Rinkel GJE, van der Graaf Y, et al. Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke. 1999;30:470-476.
56. Kuether TA, Nesbit GM, Barnwell SL. Clinical and angiographic outcomes, with treatment data, for patients with cerebral aneurysms treated with Guglielmi detachable coils: a single-center experience. Neurosurgery. 1998;43:1016-1025.
57. Malisch TW, Guglielmi G, Vinuela F, et al. Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. J Neurosurg. 1997;87:176-183.
58. Makoui AS, Smith DA, Evans AJ, et al. Early aneurysm recurrence after technically satisfactory Guglielmi detachable coil therapy: is early surveillance needed? J Neurosurg. 2000;92:355-358.
59. Vanninen R, Koivisto T, Saari T, et al. Ruptured intracranial aneurysms: acute endovascular treatment with electrolytically detachable coils-a prospective randomized study. Radiology. 1999;211:325-336.
60. Koivisto T, Vanninen R, Hurskainen H, et al. Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomized study. Stroke. 2000;31:2369-2377.
61. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet. 2002;360:1267-1274.
62. Qureshi AI, Suri MF, Hanel RA, et al. Trends in morbidity and mortality associated with hospitalization for ruptured and unruptured intracranial aneurysms in the United States [Abstract]. Stroke. 2002;33:353.
63. Johnston SC, Dudley RA, Gress DR, et al. Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals. Neurology. 1999;52:1799-1805.
64. Johnston SC, Zhao S, Dudley RA, et al. Treatment of unruptured cerebral aneurysms in California. Stroke. 2001;32:597-605.
65. Johnston SC, Wilson CB, Halbach VV, et al. Endovascular and surgical treatment of unruptured cerebral aneurysms: comparison of risks. Ann Neurol. 2000;48:11-19.
66. Vinuela F, Dion JE, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg. 1991;75:856-864.
67. Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32:1458-1471.
68. Purdy PD, Batjer HH, Risser RC, et al. Arteriovenous malformations of the brain: choosing embolic materials to enhance safety and ease of excision. J Neurosurg. 1992;77:217-222.
69. Henkes H, Nahser HC, Berg-Dammer E, et al. Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res. 1998;20:479-492.
70. Jafar JJ, Davis AJ, Berenstein A, et al. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg. 1993;78:60-69.
71. DeMeritt JS, Pile-Spellman J, Mast H, et al. Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neurorad. 1995;16:1801-1807.
72. n-BCA Trial Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neurorad. 2002;23:748-755.
73. Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg. 1996;85:19-28.
74. Roy D, Raymond J. The role of transvenous embolization in the treatment of intracranial durai arteriovenous fistulas. Neurosurgery. 1997;40:1133-1144.
75. Murphy KJ, Gailloud P, Venbrux A, et al. Endovascular treatment of a grade IV transverse sinus durai arteriovenous fistula by sinus recanalization, angioplasty, and stent placement: technical case report. Neurosurgery. 2000;46:497-501.
76. Li Y, Chen J, Wang L, et al. Treatment of stroke in a rat with intracarotid administration of marrow stromal cells. Neurology. 2001;56:1666-1672.
77. Zlokovic BV, Apuzzo ML. Cellular and molecular neurosurgery: pathways from concept to reality: vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery. 1997;40:805-813.